Real Time PCR and Culture-Based Virus Isolation Test in Clinically Recovered Patients: Is the Subject Still Infectious for SARS-CoV2?

Background. The highly variable manifestation of the COVID-19 disease, from completely asymptomatic to fatal, is both a clinical and a public health issue. The criteria for discharge of hospitalized patients have been based so far on the negative result of Real-Time Reverse Transcriptase Polymerase...

Full description

Bibliographic Details
Main Authors: Viviana Manzulli, Giulia Scioscia, Giulio Giganti, Maria Rosaria Capobianchi, Donato Lacedonia, Lorenzo Pace, Dora Cipolletta, Pasquale Tondo, Rosella De Nittis, Valeria Rondinone, Luigina Serrecchia, Antonio Parisi, Domenico Galante, Sergio Lo Caputo, Teresa Antonia Santantonio, Damiana Moschetta, Vitangelo Dattoli, Antonio Fasanella, Maria Pia Foschino Barbaro
Format: Article
Language:English
Published: MDPI AG 2021-01-01
Series:Journal of Clinical Medicine
Subjects:
Online Access:https://www.mdpi.com/2077-0383/10/2/309
id doaj-230e00e70ca74e1e9560b20b3822e28d
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Viviana Manzulli
Giulia Scioscia
Giulio Giganti
Maria Rosaria Capobianchi
Donato Lacedonia
Lorenzo Pace
Dora Cipolletta
Pasquale Tondo
Rosella De Nittis
Valeria Rondinone
Luigina Serrecchia
Antonio Parisi
Domenico Galante
Sergio Lo Caputo
Teresa Antonia Santantonio
Damiana Moschetta
Vitangelo Dattoli
Antonio Fasanella
Maria Pia Foschino Barbaro
spellingShingle Viviana Manzulli
Giulia Scioscia
Giulio Giganti
Maria Rosaria Capobianchi
Donato Lacedonia
Lorenzo Pace
Dora Cipolletta
Pasquale Tondo
Rosella De Nittis
Valeria Rondinone
Luigina Serrecchia
Antonio Parisi
Domenico Galante
Sergio Lo Caputo
Teresa Antonia Santantonio
Damiana Moschetta
Vitangelo Dattoli
Antonio Fasanella
Maria Pia Foschino Barbaro
Real Time PCR and Culture-Based Virus Isolation Test in Clinically Recovered Patients: Is the Subject Still Infectious for SARS-CoV2?
Journal of Clinical Medicine
cell culture
COVID-19
RT-PCR
SARS-CoV-2
viral transmission
author_facet Viviana Manzulli
Giulia Scioscia
Giulio Giganti
Maria Rosaria Capobianchi
Donato Lacedonia
Lorenzo Pace
Dora Cipolletta
Pasquale Tondo
Rosella De Nittis
Valeria Rondinone
Luigina Serrecchia
Antonio Parisi
Domenico Galante
Sergio Lo Caputo
Teresa Antonia Santantonio
Damiana Moschetta
Vitangelo Dattoli
Antonio Fasanella
Maria Pia Foschino Barbaro
author_sort Viviana Manzulli
title Real Time PCR and Culture-Based Virus Isolation Test in Clinically Recovered Patients: Is the Subject Still Infectious for SARS-CoV2?
title_short Real Time PCR and Culture-Based Virus Isolation Test in Clinically Recovered Patients: Is the Subject Still Infectious for SARS-CoV2?
title_full Real Time PCR and Culture-Based Virus Isolation Test in Clinically Recovered Patients: Is the Subject Still Infectious for SARS-CoV2?
title_fullStr Real Time PCR and Culture-Based Virus Isolation Test in Clinically Recovered Patients: Is the Subject Still Infectious for SARS-CoV2?
title_full_unstemmed Real Time PCR and Culture-Based Virus Isolation Test in Clinically Recovered Patients: Is the Subject Still Infectious for SARS-CoV2?
title_sort real time pcr and culture-based virus isolation test in clinically recovered patients: is the subject still infectious for sars-cov2?
publisher MDPI AG
series Journal of Clinical Medicine
issn 2077-0383
publishDate 2021-01-01
description Background. The highly variable manifestation of the COVID-19 disease, from completely asymptomatic to fatal, is both a clinical and a public health issue. The criteria for discharge of hospitalized patients have been based so far on the negative result of Real-Time Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) tests, but the persistence of viral fragments may exceed that of the integral virus by weeks. The aim of our study was to verify the clearance of the virus at viral culture in patients hospitalized for COVID-19 that have clinically recovered but are still positive on nasopharyngeal swab. Methods. The study was conducted in hospitalized patients with positive RT-PCR on nasopharyngeal swab. Patients included were from asymptomatic to severe cases and performed nasopharyngeal control swabbing on day 14 for asymptomatic patient or at least three days after remission of symptoms. RT-PCR positive specimens were sent to a biosafety level 3 laboratory for viral culture. Results. We performed a combined analysis of RT-PCR and a highly sensitive in vitro culture from 84 samples of hospitalized patients. The average age was 46 ± 20.29, and 40.5% of the subjects had radiologically confirmed pneumonia, with average PaO<sub>2</sub> of 72.35 ± 12.12and P/F ratio of 315 ± 83.15. Ct values for the N gene were lower in the first swab than in the control one (<i>p </i>< 0.001). The samples from 83 patients were negative at viral culture, and RT-PCR on the respective supernatants always confirmed the absence of viral growth. Conclusions. Our preliminary results demonstrate that patients clinically recovered for at least three days show the viral clearance at viral culture, and presumably they continued to not be contagious.
topic cell culture
COVID-19
RT-PCR
SARS-CoV-2
viral transmission
url https://www.mdpi.com/2077-0383/10/2/309
work_keys_str_mv AT vivianamanzulli realtimepcrandculturebasedvirusisolationtestinclinicallyrecoveredpatientsisthesubjectstillinfectiousforsarscov2
AT giuliascioscia realtimepcrandculturebasedvirusisolationtestinclinicallyrecoveredpatientsisthesubjectstillinfectiousforsarscov2
AT giuliogiganti realtimepcrandculturebasedvirusisolationtestinclinicallyrecoveredpatientsisthesubjectstillinfectiousforsarscov2
AT mariarosariacapobianchi realtimepcrandculturebasedvirusisolationtestinclinicallyrecoveredpatientsisthesubjectstillinfectiousforsarscov2
AT donatolacedonia realtimepcrandculturebasedvirusisolationtestinclinicallyrecoveredpatientsisthesubjectstillinfectiousforsarscov2
AT lorenzopace realtimepcrandculturebasedvirusisolationtestinclinicallyrecoveredpatientsisthesubjectstillinfectiousforsarscov2
AT doracipolletta realtimepcrandculturebasedvirusisolationtestinclinicallyrecoveredpatientsisthesubjectstillinfectiousforsarscov2
AT pasqualetondo realtimepcrandculturebasedvirusisolationtestinclinicallyrecoveredpatientsisthesubjectstillinfectiousforsarscov2
AT roselladenittis realtimepcrandculturebasedvirusisolationtestinclinicallyrecoveredpatientsisthesubjectstillinfectiousforsarscov2
AT valeriarondinone realtimepcrandculturebasedvirusisolationtestinclinicallyrecoveredpatientsisthesubjectstillinfectiousforsarscov2
AT luiginaserrecchia realtimepcrandculturebasedvirusisolationtestinclinicallyrecoveredpatientsisthesubjectstillinfectiousforsarscov2
AT antonioparisi realtimepcrandculturebasedvirusisolationtestinclinicallyrecoveredpatientsisthesubjectstillinfectiousforsarscov2
AT domenicogalante realtimepcrandculturebasedvirusisolationtestinclinicallyrecoveredpatientsisthesubjectstillinfectiousforsarscov2
AT sergiolocaputo realtimepcrandculturebasedvirusisolationtestinclinicallyrecoveredpatientsisthesubjectstillinfectiousforsarscov2
AT teresaantoniasantantonio realtimepcrandculturebasedvirusisolationtestinclinicallyrecoveredpatientsisthesubjectstillinfectiousforsarscov2
AT damianamoschetta realtimepcrandculturebasedvirusisolationtestinclinicallyrecoveredpatientsisthesubjectstillinfectiousforsarscov2
AT vitangelodattoli realtimepcrandculturebasedvirusisolationtestinclinicallyrecoveredpatientsisthesubjectstillinfectiousforsarscov2
AT antoniofasanella realtimepcrandculturebasedvirusisolationtestinclinicallyrecoveredpatientsisthesubjectstillinfectiousforsarscov2
AT mariapiafoschinobarbaro realtimepcrandculturebasedvirusisolationtestinclinicallyrecoveredpatientsisthesubjectstillinfectiousforsarscov2
_version_ 1724336088833589248
spelling doaj-230e00e70ca74e1e9560b20b3822e28d2021-01-16T00:04:08ZengMDPI AGJournal of Clinical Medicine2077-03832021-01-011030930910.3390/jcm10020309Real Time PCR and Culture-Based Virus Isolation Test in Clinically Recovered Patients: Is the Subject Still Infectious for SARS-CoV2?Viviana Manzulli0Giulia Scioscia1Giulio Giganti2Maria Rosaria Capobianchi3Donato Lacedonia4Lorenzo Pace5Dora Cipolletta6Pasquale Tondo7Rosella De Nittis8Valeria Rondinone9Luigina Serrecchia10Antonio Parisi11Domenico Galante12Sergio Lo Caputo13Teresa Antonia Santantonio14Damiana Moschetta15Vitangelo Dattoli16Antonio Fasanella17Maria Pia Foschino Barbaro18Istituto Zooprofilattico Sperimentale of Puglia and Basilicata, 71121 Foggia, ItalyRespiratory Diseases Unit, Department of Medical and Surgical Sciences, University Hospital “PoliclinicoRiuniti”, 71122 Foggia, ItalyRespiratory Diseases Unit, Department of Medical and Surgical Sciences, University Hospital “PoliclinicoRiuniti”, 71122 Foggia, ItalyLaboratory of Virology, National Institute for Infectious Diseases “L. Spallanzani”, 00149 Roma, ItalyRespiratory Diseases Unit, Department of Medical and Surgical Sciences, University Hospital “PoliclinicoRiuniti”, 71122 Foggia, ItalyIstituto Zooprofilattico Sperimentale of Puglia and Basilicata, 71121 Foggia, ItalyIstituto Zooprofilattico Sperimentale of Puglia and Basilicata, 71121 Foggia, ItalyRespiratory Diseases Unit, Department of Medical and Surgical Sciences, University Hospital “PoliclinicoRiuniti”, 71122 Foggia, ItalyClinical Pathology Department, University Hospital “PoliclinicoRiuniti”, 71122 Foggia, ItalyIstituto Zooprofilattico Sperimentale of Puglia and Basilicata, 71121 Foggia, ItalyIstituto Zooprofilattico Sperimentale of Puglia and Basilicata, 71121 Foggia, ItalyIstituto Zooprofilattico Sperimentale of Puglia and Basilicata, 71121 Foggia, ItalyIstituto Zooprofilattico Sperimentale of Puglia and Basilicata, 71121 Foggia, ItalyInfectious Diseases Unit, Department of Clinical and Experimental Medicine, University Hospital “Policlinico Riuniti”, 71122 Foggia, ItalyInfectious Diseases Unit, Department of Clinical and Experimental Medicine, University Hospital “Policlinico Riuniti”, 71122 Foggia, ItalyRespiratory Diseases Unit, Department of Medical and Surgical Sciences, University Hospital “PoliclinicoRiuniti”, 71122 Foggia, ItalyUniversity Hospital “Policlinico Riuniti”, 71122 Foggia, ItalyIstituto Zooprofilattico Sperimentale of Puglia and Basilicata, 71121 Foggia, ItalyRespiratory Diseases Unit, Department of Medical and Surgical Sciences, University Hospital “PoliclinicoRiuniti”, 71122 Foggia, ItalyBackground. The highly variable manifestation of the COVID-19 disease, from completely asymptomatic to fatal, is both a clinical and a public health issue. The criteria for discharge of hospitalized patients have been based so far on the negative result of Real-Time Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) tests, but the persistence of viral fragments may exceed that of the integral virus by weeks. The aim of our study was to verify the clearance of the virus at viral culture in patients hospitalized for COVID-19 that have clinically recovered but are still positive on nasopharyngeal swab. Methods. The study was conducted in hospitalized patients with positive RT-PCR on nasopharyngeal swab. Patients included were from asymptomatic to severe cases and performed nasopharyngeal control swabbing on day 14 for asymptomatic patient or at least three days after remission of symptoms. RT-PCR positive specimens were sent to a biosafety level 3 laboratory for viral culture. Results. We performed a combined analysis of RT-PCR and a highly sensitive in vitro culture from 84 samples of hospitalized patients. The average age was 46 ± 20.29, and 40.5% of the subjects had radiologically confirmed pneumonia, with average PaO<sub>2</sub> of 72.35 ± 12.12and P/F ratio of 315 ± 83.15. Ct values for the N gene were lower in the first swab than in the control one (<i>p </i>< 0.001). The samples from 83 patients were negative at viral culture, and RT-PCR on the respective supernatants always confirmed the absence of viral growth. Conclusions. Our preliminary results demonstrate that patients clinically recovered for at least three days show the viral clearance at viral culture, and presumably they continued to not be contagious.https://www.mdpi.com/2077-0383/10/2/309cell cultureCOVID-19RT-PCRSARS-CoV-2viral transmission